Followers | 29 |
Posts | 2446 |
Boards Moderated | 0 |
Alias Born | 11/22/2010 |
Thursday, June 03, 2021 10:24:28 AM
gut says something is in the works, no reason to do all this backoffice if some deal or some pending development is not highly probable.
The board, insiders, and a couple of their listed employees are no fools. Their time is worth money; they are not nickel and dimers. They are associated with substantial money as well as current and recent past significant industry success.
These peoples association would have terminated long ago if the upside potential was not only significant but also probable. JMO
A million or even couple million shares dispersed to loyal participants aren't individually worth squat at current share price, nor a small multiple therin. $50K, $100K? doesn't get interesting to them (even smaller insiders) on a multi-year involvement short of $250k-$500K+ JMO that gives us a 5x-10x multiple potentials from .08
as such my short/medium-term target is that we see .40 - .60 (before Dec)
mark this post and Laugh Out Load and ridicule me later ;)
heck, ridicule me now. I only risk what I'm prepared to lose.
I'm one year in from initiating a position that I added all the way up to something like 30K at .044 on tax loss selling last December.
Long, Strong and arguably foolish for not selling significantly into the pop over .20
in frustrastion I've added another 100K or so under .09 this time around.
Neil might be targeting .25... me? double that on good news with real $$ attached.
I want to get into a lower capital gains bracket before I sell.
good luck to all.
Recent PLSH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 01:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 03:28:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 07:24:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/08/2023 08:04:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 05:07:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:15:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 04:21:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 03:28:18 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 03:19:11 PM
- Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast • InvestorsHub NewsWire • 07/18/2023 04:41:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 01:00:13 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM